GENE ONLINE|News &
Opinion
Blog

2022-01-17|

ARM 2022: Industry Briefs on Cell and Gene Therapies

by Sahana Shankar
Share To
One global network, the Alliance for Regenerative Medicine (ARM), represents 400 members from industry and academia in advocating for innovations and support of cell, gene, tissue-based advanced therapies. At the ARM’s virtual 2022 Cell & Gene State of the Industry Briefing, two experts highlighted the sector’s progress in 2021 and welcomed industry experts to share their views on the promising future of regenerative medicine in 2022 and 2023. The speakers are: 

It's free! Log in now to read

LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!